Recent articles

You rode. We cheered you on. Together, we fueled type 1 diabetes breakthroughs! Read our wrap-up of the Breakthrough T1D Ride 2025 season.

Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.

Through grassroots support, Breakthrough T1D advocates help advance treatments, influence policy, and improve global access to care.

What’s happening? Today, Breakthrough T1D co-hosted an event with leading international diabetes organizations to discuss cardiovascular disease (CVD) and type 1 diabetes (T1D)—where we are, challenges that remain, and how we can work together in Europe and beyond to address this need for the T1D community. The focus of the event: Doing more for CVD […]

What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]

There are three ways we can get to cures for type 1 diabetes faster: cell therapies, early detection, and disease-modifying therapies.

Building awareness and understanding about T1D is more important than ever. Together, our stories change how people see T1D.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.